Skip to main content
. 2023 Feb 11;58(4):313–345. doi: 10.1007/s00535-023-01958-z
Statement 1.4: While disease signs and symptoms are often the first indicator that treatment is suboptimal, treatment escalation should not be undertaken without confirming the presence of ongoing intestinal inflammation (Evidence level 3, 5)

Voting agreement rate

44/44 (100%)